Accéder au contenu
Merck

Prevalence of sarcopenia and associated factors in the healthy older adults of the Peruvian Andes.

Archives of gerontology and geriatrics (2016-09-21)
Alessandra Tramontano, Nicola Veronese, Giuseppe Sergi, Enzo Manzato, Diana Rodriguez-Hurtado, Stefania Maggi, Caterina Trevisan, Francesca De Zaiacomo, Valter Giantin
RÉSUMÉ

To assess the prevalence of sarcopenia and associated factors in a population of older people living in a rural area of the Peruvian Andes. The study concerned 222 people aged ≥65 years. Sarcopenia was diagnosed on the basis of skeletal muscle mass, measured using bioimpedance analysis, and gait speed, measured with the 4-m walking test, as recommended by the International Working Group on sarcopenia. Self-reported physical activity, the Short Physical Performance Battery, and the Six-Minute Walking Test also contributed information on participants' physical performance status. Disabilities were investigated by assessing participants' self-reported difficulties in performing one or more basic or instrumental activities of daily living. The prevalence of sarcopenia was 17.6%. Compared with participants without sarcopenia, individuals who were found sarcopenic were significantly older, female and were less frequently farmers, had fewer children, had a worse nutritional status, a significantly lower physical performance, and higher levels of disability in the instrumental activities of daily living. After adjusting for potential confounders, age, female sex, a low body mass index, a self-reported low physical activity level, a worse Six-Minute Walking Test scores, and a low number of children were significantly associated with sarcopenia. The prevalence of sarcopenia seems to be quite high among community-dwelling older subjects in the Peruvian Andes. Age, female sex, a low body mass index, little physical activity, a poor Six-Minute Walking Test scores, and a low number of children could be associated with this condition.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
BIO-Acetoxime, ≥98% (HPLC)